Emerging evidence suggests that TGF-α/EGFR signaling plays a pivotal role in tumor cell proliferation, differentiation, and survival, raising the possibility that TGFA itself may represent a novel glioma susceptibility locus and therapeutic target (7, 9–11). Here, EGFR is linked to central nervous system cancer.